Sphingosine 1-phosphate (S1P) signals via its cell-surface G protein-coupled receptors to regulate vascular permeability, inflammation, angiogenesis and vascular maturation. In the past funding period, we found that apolipoprotein M (ApoM) is required for S1P to be associated with HDL and that ApoM+HDL activates the endothelial S1P1 receptor to induce vascular homeostasis and inhibit inflammatory responses. Recent findings also revealed a novel function of ApoM+HDL in the suppression of lymphopoiesis. In addition, we uncovered that the S1P1 receptor is a critical proximal component of shear stress sensing in the vascular endothelium and regulates vascular development and homeostasis. This renewal application aims to further elucidate this fundamental signaling system vascular and immune systems. Since S1P receptor modulators are now used in the clinic to treat autoimmune conditions, it is important to fully define this signaling system and to understand the cardiovascular implications. The overarching hypothesis of this proposal is that an HDL-bound ApoM/ S1P complex in plasma activates S1P receptors to regulate physiologic vascular development and homeostasis as well as immune homeostasis. The balanced activation of multiple S1P receptors by HDL/S1P plays a critical role in normal health of the vascular system and if dysregulated, leads to vascular disease. We propose to elucidate the mechanisms by which ApoM+HDL delivers S1P to its receptors on endothelial cells and regulates biological effects. Second, the physiological importance of ApoM+HDL to regulate vascular inflammation via S1P receptors will be examined in mouse and fish models. Biochemical analysis in cultured endothelial cells, genetic loss-of-function studies in zebrafish and genetic mouse models of receptor function will be conducted to further define the key S1P pathway components. Third, we will explore the novel finding that ApoM+HDL signaling via S1P receptors restrain lymphopoiesis. The concept that ApoM+HDL/S1P regulates immune ontogeny while albumin/S1P mediates immune cell trafficking will be tested rigorously. Therapeutic opportunities with reconstituted ApoM+HDL will be explored. Since S1P receptor modulators have entered the therapeutic era, the findings from this project are likely to have rapid translational potential.

Public Health Relevance

Cardiovascular disease causes major mortality and morbidity in developed and newly developing nations. Injury of endothelial cells of blood vessels is a major cause of the development of heart disease by causing fatty lesions in arteries called atherosclerotic plaques. In this proposal, we will examine the hypothesis that a lipid mediator called sphingosine 1-phosphate (S1P) acts on its receptors on endothelial cells to protect the endothelial cells and thereby retard the development of atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL089934-06A1
Application #
8689590
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Gao, Yunling
Project Start
2007-07-01
Project End
2018-03-31
Budget Start
2014-04-04
Budget End
2015-03-31
Support Year
6
Fiscal Year
2014
Total Cost
$423,750
Indirect Cost
$173,750
Name
Weill Medical College of Cornell University
Department
Pathology
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Xiong, Yuquan; Yang, Peiying; Proia, Richard L et al. (2014) Erythrocyte-derived sphingosine 1-phosphate is essential for vascular development. J Clin Invest 124:4823-8
Xiong, Yuquan; Hla, Timothy (2014) S1P control of endothelial integrity. Curr Top Microbiol Immunol 378:85-105
Montrose, David C; Scherl, Ellen J; Bosworth, Brian P et al. (2013) S1P? localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity. J Lipid Res 54:843-51
Mendelson, Karen; Zygmunt, Tomasz; Torres-Vazquez, Jesus et al. (2013) Sphingosine 1-phosphate receptor signaling regulates proper embryonic vascular patterning. J Biol Chem 288:2143-56
Garris, Christopher S; Wu, Linfeng; Acharya, Swati et al. (2013) Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol 14:1166-72
Xiong, Yuquan; Lee, Hyeuk Jong; Mariko, Boubacar et al. (2013) Sphingosine kinases are not required for inflammatory responses in macrophages. J Biol Chem 288:32563-73
Obinata, Hideru; Hla, Timothy (2012) Sphingosine 1-phosphate in coagulation and inflammation. Semin Immunopathol 34:73-91
Oo, Myat Lin; Chang, Sung-Hee; Thangada, Shobha et al. (2011) Engagement of S1Pýýý-degradative mechanisms leads to vascular leak in mice. J Clin Invest 121:2290-300
Hla, Timothy; Brinkmann, Volker (2011) Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation. Neurology 76:S3-8
Chang, Sung-Hee; Hla, Timothy (2011) Gene regulation by RNA binding proteins and microRNAs in angiogenesis. Trends Mol Med 17:650-8

Showing the most recent 10 out of 22 publications